Accurate assessment of the need for glucocorticoid therapy is essential after transsphenoidal surgery (TSS) for pituitary tumors. Agreement on the best test to use in the early postoperative setting is lacking.
Recovery Room Cortisol Predicts Long-Term Glucocorticoid Need After Transsphenoidal Surgery for Pituitary TumorsAmro Qaddoura, BHSc; Tenzin N. Shalung, BSc; Michael P. Meier, MD; et al. Neurosurgery. published online ahead of print: March 20, 2018.
Guidelines on the Management of Patients with Nonfunctioning Pituitary Adenomas (Neurosurgery)
Endoscopic Series #1Introduction to Endoscopic Endonasal Surgery (CME)
Endoscopic Series #2Pituitary Tumors and CSF Leaks (CME)
SANS: Pituitary Adenoma 2018 (CME)
54 year-old male with weight gain and irritability
Suprasellar Mass in a Child
Growth Arrest in a 9-year-old Boy
Graded Repair of Cranial Base Defects and Cerebrospinal Fluid Leaks in Transsphenoidal SurgeryEsposito F, Dusick JR, Fatemi N, Kelly DF. Oper Neurosurg. 2007;60(suppl_4):ONS-295-ONS-304.
The Endonasal Microscopic Approach for Pituitary Adenomas and Other Parasellar Tumors: A 10-year ExperienceFatemi N, Dusick JF, de Paiva Neto MA, Kelly DF. Oper Neurosurg. 2008;63(suppl_4):ONS244-ONS256.
To foster scientific discovery and innovative research seeking to better the lives of patients suffering neurological and surgical disorders.